Legal & General Group’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-620
| Closed | -$4.4K | – | 3556 |
|
|
2025
Q1 | $4.4K | Hold |
620
| – | – | ﹤0.01% | 3296 |
|
|
2024
Q4 | $13.7K | Hold |
620
| – | – | ﹤0.01% | 3169 |
|
|
2024
Q3 | $12.5K | Hold |
620
| – | – | ﹤0.01% | 3226 |
|
|
2024
Q2 | $10.8K | Buy |
620
+242
| +64% | +$4.21K | ﹤0.01% | 3284 |
|
|
2024
Q1 | $15.7K | Hold |
378
| – | – | ﹤0.01% | 3062 |
|
|
2023
Q4 | $9.5K | Hold |
378
| – | – | ﹤0.01% | 3246 |
|
|
2023
Q3 | $12.3K | Sell |
378
-69
| -15% | -$2.25K | ﹤0.01% | 3224 |
|
|
2023
Q2 | $26K | Buy |
+447
| New | +$26K | ﹤0.01% | 3002 |
|
|
2021
Q2 | – | Sell |
-47
| Closed | -$12K | – | 3665 |
|
|
2021
Q1 | $12K | Hold |
47
| – | – | ﹤0.01% | 3331 |
|
|
2020
Q4 | $9K | Hold |
47
| – | – | ﹤0.01% | 3376 |
|
|
2020
Q3 | $10K | Sell |
47
-15
| -24% | -$3.19K | ﹤0.01% | 3240 |
|
|
2020
Q2 | $17K | Sell |
62
-17
| -22% | -$4.66K | ﹤0.01% | 3141 |
|
|
2020
Q1 | $21K | Sell |
79
-4
| -5% | -$1.06K | ﹤0.01% | 2897 |
|
|
2019
Q4 | $27K | Buy |
83
+17
| +26% | +$5.53K | ﹤0.01% | 3097 |
|
|
2019
Q3 | $25K | Buy |
66
+27
| +69% | +$10.2K | ﹤0.01% | 3060 |
|
|
2019
Q2 | $17K | Buy |
39
+35
| +875% | +$15.3K | ﹤0.01% | 3261 |
|
|
2019
Q1 | $2K | Hold |
4
| – | – | ﹤0.01% | 3336 |
|
|
2018
Q4 | $2K | Hold |
4
| – | – | ﹤0.01% | 3372 |
|
|
2018
Q3 | $1K | Hold |
4
| – | – | ﹤0.01% | 3385 |
|
|
2018
Q2 | $3K | Hold |
4
| – | – | ﹤0.01% | 3341 |
|
|
2018
Q1 | $18K | Buy |
+4
| New | +$18K | ﹤0.01% | 3132 |
|